Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection.

O'Shea MK, Tanner R, Müller J, Harris SA, Wright D, Stockdale L, Stylianou E, Satti I, Smith SG, Dunbar J, Fletcher TE, Dedicoat M, Cunningham AF, McShane H.

Sci Rep. 2018 Sep 27;8(1):14480. doi: 10.1038/s41598-018-32755-x.

2.

Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.

Chiacchio T, Delogu G, Vanini V, Cuzzi G, De Maio F, Pinnetti C, Sampaolesi A, Antinori A, Goletti D.

PLoS One. 2017 Aug 24;12(8):e0183846. doi: 10.1371/journal.pone.0183846. eCollection 2017.

3.
4.

Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.

Delogu G, Vanini V, Cuzzi G, Chiacchio T, De Maio F, Battah B, Pinnetti C, Sampaolesi A, Antinori A, Goletti D.

Scand J Immunol. 2016 Dec;84(6):344-352. doi: 10.1111/sji.12493.

5.

[Biologics and mycobacterial diseases].

Tsuyuguchi K, Matsumoto T.

Kekkaku. 2013 Mar;88(3):337-53. Japanese.

PMID:
23672175
6.

[Evolution of IGRA researches].

Ariga H, Harada N.

Kekkaku. 2008 Sep;83(9):641-52. Review. Japanese.

PMID:
18979999
7.

Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.

Baguma R, Penn-Nicholson A, Smit E, Erasmus M, Day J, Makhethe L, de Kock M, Hughes EJ, van Rooyen M, Pienaar B, Stone L, Hanekom W, Brennan MJ, Wallis RS, Hatherill M, Scriba TJ.

PLoS One. 2017 Sep 8;12(9):e0184563. doi: 10.1371/journal.pone.0184563. eCollection 2017.

8.

The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7.

Kim SY, Park MS, Kim YS, Kim SK, Chang J, Lee HJ, Cho SN, Kang YA.

Scand J Immunol. 2012 Dec;76(6):580-6. doi: 10.1111/j.1365-3083.2012.02776.x.

9.

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection.

Lee H, Kim J, Kang YA, Kim DR, Sim B, Zelmer A, Fletcher HA, Dockrell HM, Smith SG, Cho SN.

Front Immunol. 2019 Apr 26;10:896. doi: 10.3389/fimmu.2019.00896. eCollection 2019.

10.

Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.

Yang X, Wu JB, Liu Y, Xiong Y, Ji P, Wang SJ, Chen Y, Zhao GP, Lu SH, Wang Y.

Tuberculosis (Edinb). 2017 Dec;107:119-125. doi: 10.1016/j.tube.2017.08.005. Epub 2017 Aug 31.

PMID:
29050758
11.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
12.

The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.

Biraro IA, Kimuda S, Egesa M, Cose S, Webb EL, Joloba M, Smith SG, Elliott AM, Dockrell HM, Katamba A.

PLoS One. 2016 Jan 15;11(1):e0146098. doi: 10.1371/journal.pone.0146098. eCollection 2016.

13.

Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load.

Day CL, Abrahams DA, Lerumo L, Janse van Rensburg E, Stone L, O'rie T, Pienaar B, de Kock M, Kaplan G, Mahomed H, Dheda K, Hanekom WA.

J Immunol. 2011 Sep 1;187(5):2222-32. doi: 10.4049/jimmunol.1101122. Epub 2011 Jul 20.

14.

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.

Houben RM, Dodd PJ.

PLoS Med. 2016 Oct 25;13(10):e1002152. doi: 10.1371/journal.pmed.1002152. eCollection 2016 Oct. Review.

15.

Multifunctional Analysis of CD4+ T-Cell Response as Immune-Based Model for Tuberculosis Detection.

Lichtner M, Mascia C, Sauzullo I, Mengoni F, Vita S, Marocco R, Belvisi V, Russo G, Vullo V, Mastroianni CM.

J Immunol Res. 2015;2015:217287. doi: 10.1155/2015/217287. Epub 2015 Aug 3.

16.

Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.

Jeong YH, Hur YG, Lee H, Kim S, Cho JE, Chang J, Shin SJ, Lee H, Kang YA, Cho SN, Ha SJ.

J Clin Microbiol. 2015 Feb;53(2):504-10. doi: 10.1128/JCM.02758-14. Epub 2014 Nov 26.

17.

Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment.

Chiacchio T, Petruccioli E, Pepponi I, Vanini V, Gualano G, Cirillo D, Palmieri F, Ippolito G, Goletti D.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S141-S142. doi: 10.1016/j.ijmyco.2016.09.034. Epub 2016 Nov 11.

18.

Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.

Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N.

Front Immunol. 2014 Apr 22;5:180. doi: 10.3389/fimmu.2014.00180. eCollection 2014. Review.

19.

Immune responses to latent tuberculosis antigen Rv2659c in Chinese populations.

Bai XJ, Liang Y, Yang YR, Li N, Zhang XY, An HR, Zhang JX, Chen D, Wang L, Wu XQ.

J Microbiol Immunol Infect. 2015 Aug;48(4):381-9. doi: 10.1016/j.jmii.2014.02.006. Epub 2014 Apr 22.

20.

Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection.

Pan L, Wei N, Jia H, Gao M, Chen X, Wei R, Sun Q, Gu S, Du B, Xing A, Zhang Z.

Oncotarget. 2017 Dec 4;8(68):112907-112916. doi: 10.18632/oncotarget.22889. eCollection 2017 Dec 22.

Supplemental Content

Support Center